المؤلفون: Tiina Reinivuori, Pekka Kurki, Paul T. Chamberlain

المصدر: Pharmaceutical Medicine. 32:103-121

مصطلحات موضوعية: 0301 basic medicine, Pharmacology, Computer science, Immunogenicity, Pharmacology toxicology, Authorization, Biosimilar, Double blind, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Risk analysis (engineering), 030220 oncology & carcinogenesis, Drug interference, media_common.cataloged_instance, Pharmacology (medical), European union, Clinical evaluation, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::454c95ad96b3aff87b39f08ca60f2d85
https://doi.org/10.1007/s40290-018-0231-0